CA2589989A1 - The use of the neurotoxic component of a botulinum toxin for the treatment of exessive sweating - Google Patents
The use of the neurotoxic component of a botulinum toxin for the treatment of exessive sweatingInfo
- Publication number
- CA2589989A1 CA2589989A1 CA002589989A CA2589989A CA2589989A1 CA 2589989 A1 CA2589989 A1 CA 2589989A1 CA 002589989 A CA002589989 A CA 002589989A CA 2589989 A CA2589989 A CA 2589989A CA 2589989 A1 CA2589989 A1 CA 2589989A1
- Authority
- CA
- Canada
- Prior art keywords
- botulinum toxin
- sweating
- exessive
- treatment
- neurotoxic component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention provides a method for relieving pain, associated with muscle contractions, a composition and a method of treating conditions such as cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretions and a method for treating smooth muscle disorders including, but not limited to, spasms in the sphincter of the cardiovascular arteriole, gastrointestinal system, urinary, gall bladder and rectum, which method comprises administering to the patient suffering from said disorder or condition a therapeutically effective amount of Botulinum toxin selected from a group consisting of Botulinum toxin types B, C, D, E, F and G.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17399693A | 1993-12-28 | 1993-12-28 | |
US08/173,996 | 1993-12-28 | ||
CA002300766A CA2300766C (en) | 1993-12-28 | 1994-12-16 | Neurotoxic component of botulinum toxin for treating cervical dystonia |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002300766A Division CA2300766C (en) | 1993-12-28 | 1994-12-16 | Neurotoxic component of botulinum toxin for treating cervical dystonia |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2589989A1 true CA2589989A1 (en) | 1995-07-06 |
CA2589989C CA2589989C (en) | 2009-05-12 |
Family
ID=38236376
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002589968A Abandoned CA2589968A1 (en) | 1993-12-28 | 1994-12-16 | The use of the neurotoxic component of a botulinum toxin for the treatment of pain associated with muscle activity or contracture |
CA002590540A Expired - Lifetime CA2590540C (en) | 1993-12-28 | 1994-12-16 | The use of neurotoxic component of a botulinum toxin for the treatment of excessive mucus secretion |
CA002590537A Expired - Lifetime CA2590537C (en) | 1993-12-28 | 1994-12-16 | The use of the neurotoxin component of a botulinum toxin for the treatment of excessive lacrimation |
CA002589987A Expired - Fee Related CA2589987C (en) | 1993-12-28 | 1994-12-16 | Method for treating a cholinergic influenced secretion |
CA002590293A Expired - Lifetime CA2590293C (en) | 1993-12-28 | 1994-12-16 | Use of the neurotoxic component of botulinum to treat a spastic muscle |
CA002589989A Expired - Lifetime CA2589989C (en) | 1993-12-28 | 1994-12-16 | The use of the neurotoxic component of a botulinum toxin for the treatment of exessive sweating |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002589968A Abandoned CA2589968A1 (en) | 1993-12-28 | 1994-12-16 | The use of the neurotoxic component of a botulinum toxin for the treatment of pain associated with muscle activity or contracture |
CA002590540A Expired - Lifetime CA2590540C (en) | 1993-12-28 | 1994-12-16 | The use of neurotoxic component of a botulinum toxin for the treatment of excessive mucus secretion |
CA002590537A Expired - Lifetime CA2590537C (en) | 1993-12-28 | 1994-12-16 | The use of the neurotoxin component of a botulinum toxin for the treatment of excessive lacrimation |
CA002589987A Expired - Fee Related CA2589987C (en) | 1993-12-28 | 1994-12-16 | Method for treating a cholinergic influenced secretion |
CA002590293A Expired - Lifetime CA2590293C (en) | 1993-12-28 | 1994-12-16 | Use of the neurotoxic component of botulinum to treat a spastic muscle |
Country Status (1)
Country | Link |
---|---|
CA (6) | CA2589968A1 (en) |
-
1994
- 1994-12-16 CA CA002589968A patent/CA2589968A1/en not_active Abandoned
- 1994-12-16 CA CA002590540A patent/CA2590540C/en not_active Expired - Lifetime
- 1994-12-16 CA CA002590537A patent/CA2590537C/en not_active Expired - Lifetime
- 1994-12-16 CA CA002589987A patent/CA2589987C/en not_active Expired - Fee Related
- 1994-12-16 CA CA002590293A patent/CA2590293C/en not_active Expired - Lifetime
- 1994-12-16 CA CA002589989A patent/CA2589989C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2589987A1 (en) | 1995-07-06 |
CA2589968A1 (en) | 1995-07-06 |
CA2589987C (en) | 2008-05-20 |
CA2590537C (en) | 2009-10-13 |
CA2590540A1 (en) | 1995-07-06 |
CA2589989C (en) | 2009-05-12 |
CA2590293A1 (en) | 1995-07-06 |
CA2590537A1 (en) | 1995-07-06 |
CA2590293C (en) | 2009-05-12 |
CA2590540C (en) | 2009-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2180011A1 (en) | Botulinum toxins for treating sweating | |
WO1995017904B1 (en) | Botulinum toxins for treating various disorders and associated pain | |
CA2164866A1 (en) | Treatment of neuromuscular disorders and conditions with different botulinum serotype | |
EP2145629A3 (en) | Use of neurotoxin therapy for treatment of urologic and related disorders | |
JP2004518632A5 (en) | ||
CA2164626A1 (en) | Multiple botulinum toxins for treating neuromuscular disorders and conditions | |
CA2245661A1 (en) | Multiple sclerosis treatment | |
CA2071215A1 (en) | Method and composition for treating inflammatory bowel disorders | |
CA2061665A1 (en) | Treatment of lower urinary tract disorders | |
CA2275167A1 (en) | The topical use of kappa opioid agonists to treat ocular pain | |
WO2002039999B1 (en) | Use of suramine, l-histidine, quisqualic acid or d-cycloserine for angiogenesis inhibition | |
CA2136953A1 (en) | A method for using lipoprotein associated coagulation inhibitor to treat sepsis | |
CA2589989A1 (en) | The use of the neurotoxic component of a botulinum toxin for the treatment of exessive sweating | |
CA2300703A1 (en) | Method for treating excessive sweating | |
张安莉 et al. | Clinical effect of acupuncture in the treatment of gastrokinetic disturbance | |
WO1998001125A3 (en) | Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity | |
CA2149766A1 (en) | Rectal flunisolide compositions for treating inflammatory intestinal disorders | |
EP0182569A3 (en) | Use of 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyridoû1,2-a¨pyrimidine-3-carboxamide for the prevention and treatment of gastrointestinal damages | |
WO1996029076A3 (en) | Treatment of inflammatory bowel disorders with cotinine | |
Chen | Treatment of apoplectic hemiplegia by digital acupoint pressure--a report of 42 cases | |
夏晓菊 | OBSERVATION ON THE THERAPEUTIC EFFECTS OF 282 CASES WITH PAIN TREATED BY ACUPUNCTURE AT XI POINTS | |
WO1999065511A3 (en) | Composition and method for treatment of pseudomonas infection | |
RU93037466A (en) | METHOD FOR TREATING PERIPHERAL NEUROPATHIES | |
CA2287903A1 (en) | Method for treating medical conditions using a microprocessor-based video game | |
RU99111088A (en) | METHOD FOR TREATING STREPTOCOCCUS PNEUMONIAE INFECTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20141216 |